Literature DB >> 12387847

Two casein kinase 1 isoforms are differentially expressed in Trypanosoma cruzi.

Carmenza Spadafora1, Yolanda Repetto, Cristina Torres, Laura Pino, Carlos Robello, Antonio Morello, Francisco Gamarro, Santiago Castanys.   

Abstract

The cDNAs for two casein kinase 1 (CK1) homologues, TcCK1.1 and TcCK1.2, have been isolated from Trypanosoma cruzi. Both isoforms showed strong identity with other known CK1s. Their corresponding genes encode proteins of 312- and 330-amino acid residues with apparent molecular weights of 16 and 37 kDa, respectively. TcCK1.1 is a two-copy gene while TcCK1.2 is tandemly repeated, an arrangement not yet found in any other CK1. TcCK1.1 has been overexpressed in Escherichia coli and the recombinant protein exhibited properties characteristic of the CK1 family. Northern blot indicated that both TcCK1s are expressed differentially during the life stages of the parasite: the isoform TcCK1.1 shows low levels of mRNA expression in epimastigotes and increased expression in trypomastigotes while TcCK1.2 presents an augmented expression in amastigotes as compared with the other two life stages of the parasite. The CK1-like activity of amastigotes and trypomastigotes is significantly higher than that of epimastigotes and, independent of the life stage of the parasite, a constitutive activity is observed which, in the epimastigote forms, is found predominantly in the microsomal fraction. Also in the epimastigote forms, the CK1-like activity increases in the log phase of growth of the parasites, and, through synchronization studies, this activity has been most conspicuously circumscribed to the S and M phases of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387847     DOI: 10.1016/s0166-6851(02)00156-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

1.  The composition of upstream open reading frames (uORF) in four genes from Trypanosoma cruzi typical strains.

Authors:  Lauren Hubert Jaeger; Adeilton Brandão
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

2.  Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Authors:  Najma Rachidi; Jean François Taly; Emilie Durieu; Olivier Leclercq; Nathalie Aulner; Eric Prina; Pascale Pescher; Cedric Notredame; Laurent Meijer; Gerald F Späth
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.

Authors:  Jianghuai Liu; Lucas P Carvalho; Sabyasachi Bhattacharya; Christopher J Carbone; K G Suresh Kumar; N Adrian Leu; Peter M Yau; Robert G K Donald; Mitchell J Weiss; Darren P Baker; K John McLaughlin; Phillip Scott; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

Review 4.  Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates.

Authors:  Brad A Haubrich; David C Swinney
Journal:  Curr Drug Discov Technol       Date:  2016

5.  Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.

Authors:  Marilyn Parsons; Elizabeth A Worthey; Pauline N Ward; Jeremy C Mottram
Journal:  BMC Genomics       Date:  2005-09-15       Impact factor: 3.969

Review 6.  Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion.

Authors:  Najma Rachidi; Uwe Knippschild; Gerald F Späth
Journal:  Front Cell Infect Microbiol       Date:  2021-03-22       Impact factor: 5.293

7.  A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.

Authors:  Ariel José Berenstein; María Paula Magariños; Ariel Chernomoretz; Fernán Agüero
Journal:  PLoS Negl Trop Dis       Date:  2016-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.